Financial News · Live Terminal

Page 416 of 550

B. Riley Adjusts Price Target on Lumentum Holdings to $1,036 From $526, Maintains Buy Rating

Lumentum Holdings (LITE) has an average rating of overweight and mean price target of $861.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $966.88, Change: $+64.56, Percent Change: +7.15%

Financial News · Live Terminal

B. Riley Adjusts Price Target on Lumentum Holdings to $1,036 From $526, Maintains Buy Rating

BofA Securities Adjusts Sandisk Price Target to $1,550 From $1,080, Maintains Buy Rating

JPMorgan Adjusts Stryker Price Target to $400 From $445, Maintains Overweight Rating

BofA Securities Cuts Eli Lilly Price Target to $1,133 From $1,294, Maintains Buy Rating

BofA Securities Adjusts Apple Price Target to $330 From $325, Maintains Buy Rating

Evercore ISI Adjusts Invitation Homes Price Target to $32 From $29

Keefe Bruyette & Woods Adjusts Invitation Homes Price Target to $29 From $28

BofA Securities Adjusts Caterpillar Price Target to $989 From $930, Maintains Buy Rating

Oppenheimer Adjusts Price Target on Entegris to $160 From $135, Maintains Perform Rating

B. Riley Adjusts Price Target on Cohu to $60 From $50, Maintains Buy Rating

B. Riley Adjusts Price Target on ADTRAN Holdings to $21 From $16, Maintains Buy Rating

Oppenheimer Adjusts Price Target on Bel Fuse to $315 From $265, Maintains Outperform Rating

Oppenheimer Adjusts Price Target on Builders FirstSource to $121 From $150, Maintains Outperform Rating

Oppenheimer Adjusts Price Target on Custom Truck One Source Inc to $11 From $8, Maintains Outperform Rating

Oppenheimer Adjusts Price Target on Caterpillar to $980 From $832, Maintains Outperform Rating

GSK's Linerixibat Gets UK Nod for Itch Linked to Biliary Disease

Raymond James Adjusts Stryker Price Target to $383 From $418, Maintains Outperform Rating

Oppenheimer Adjusts Price Target on Amrize to $68 From $70, Maintains Outperform Rating

UBS Adjusts Price Target on Western Digital to $375 From $350, Maintains Neutral Rating

Mizuho Securities Adjusts ResMed Price Target to $235 From $255, Maintains Outperform Rating

B. Riley Adjusts Price Target on Lumentum Holdings to $1,036 From $526, Maintains Buy Rating

BofA Securities Adjusts Sandisk Price Target to $1,550 From $1,080, Maintains Buy Rating

JPMorgan Adjusts Stryker Price Target to $400 From $445, Maintains Overweight Rating

BofA Securities Cuts Eli Lilly Price Target to $1,133 From $1,294, Maintains Buy Rating

BofA Securities Adjusts Apple Price Target to $330 From $325, Maintains Buy Rating

Evercore ISI Adjusts Invitation Homes Price Target to $32 From $29

Keefe Bruyette & Woods Adjusts Invitation Homes Price Target to $29 From $28

BofA Securities Adjusts Caterpillar Price Target to $989 From $930, Maintains Buy Rating

Oppenheimer Adjusts Price Target on Entegris to $160 From $135, Maintains Perform Rating

B. Riley Adjusts Price Target on Cohu to $60 From $50, Maintains Buy Rating

B. Riley Adjusts Price Target on ADTRAN Holdings to $21 From $16, Maintains Buy Rating

Oppenheimer Adjusts Price Target on Bel Fuse to $315 From $265, Maintains Outperform Rating

Oppenheimer Adjusts Price Target on Builders FirstSource to $121 From $150, Maintains Outperform Rating

Oppenheimer Adjusts Price Target on Custom Truck One Source Inc to $11 From $8, Maintains Outperform Rating

Oppenheimer Adjusts Price Target on Caterpillar to $980 From $832, Maintains Outperform Rating

GSK's Linerixibat Gets UK Nod for Itch Linked to Biliary Disease

Raymond James Adjusts Stryker Price Target to $383 From $418, Maintains Outperform Rating

Oppenheimer Adjusts Price Target on Amrize to $68 From $70, Maintains Outperform Rating

UBS Adjusts Price Target on Western Digital to $375 From $350, Maintains Neutral Rating

Mizuho Securities Adjusts ResMed Price Target to $235 From $255, Maintains Outperform Rating